173 Avsnitt

  1. Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader

    Publicerades: 2021-07-26

  2. Ep94: Jenny Rooke on Investing in Biotech Tools

    Publicerades: 2021-07-19

  3. Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists

    Publicerades: 2021-06-14

  4. Ep92: Brad Gray on Spatial Biology

    Publicerades: 2021-06-01

  5. Ep91: Daphne Zohar on Biotech Entrepreneurship

    Publicerades: 2021-05-03

  6. Ep90: James Sabry on Partnering Amid Scientific Abundance

    Publicerades: 2021-04-19

  7. Ep89: Emily Leproust on DNA Synthesis at Scale

    Publicerades: 2021-03-29

  8. Ep88: Amy DuRoss on software and logistics for cell and gene therapy

    Publicerades: 2021-03-15

  9. Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing

    Publicerades: 2021-03-01

  10. Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

    Publicerades: 2021-02-09

  11. Ep85: Luhan Yang on CRISPR Editing for Organ Transplants

    Publicerades: 2021-01-20

  12. Ep84: Steve Paul on Treatments for Mental Health

    Publicerades: 2020-12-22

  13. Ep83: David Lee on Impact in Pharmaceuticals

    Publicerades: 2020-12-14

  14. Ep82: Andrew Farnum on Medicines From Unusual Traits

    Publicerades: 2020-11-23

  15. Ep81: Simba Gill on Microbiome Therapies

    Publicerades: 2020-11-12

  16. Ep80: Peter Kolchinsky on Pharma's Soul

    Publicerades: 2020-10-28

  17. Ep79: Daphne Koller on Machine Learning for Drug Discovery

    Publicerades: 2020-10-26

  18. Ep78: Pearl Huang on Exoneural Cancer Biology

    Publicerades: 2020-10-13

  19. Ep77: Jennifer Petter on Drugging RNA Targets

    Publicerades: 2020-09-29

  20. Ep76: Otello Stampacchia on Becoming a Biotech VC

    Publicerades: 2020-09-08

5 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site